August 20, 2014

FDA Stands Between Terminally Ill And Experimental Drugs

pin it button FDA Stands Between Terminally Ill And Experimental Drugs

Pills in bottles FDA Stands Between Terminally Ill And Experimental Drugs

By Attorney Jonathan Emord
National Health Federation

In the 1973 science fiction film Soylent Green, directed by Richard Fleisher and starring Charlton Heston as Thor, the government combined with industry to euthanize people deemed of low social utility and use their corpses to make a food source called Soylent Green, which was then fed to a starving population unaware of its true source. Whenever government supplants the right of an individual in making penultimate treatment decisions in the face of terminal illness, the people are robbed of their right to liberty and to life. The grotesque abuse of government power portrayed in Soylent Green has a modern corollary in the FDA that is equally horrific.

Under FDA regulations a patient who is terminally ill may only gain access to an investigational drug if the FDA approves. FDA approval is required even if the attending physician recommends the drug and the sponsor is willing to provide it. In this way, FDA stands between the terminally ill and access to potentially life saving drugs. Hundreds of people have been deprived of all hope and freedom of choice by the barbaric exercise of life-ending power by the Food and Drug Administration.

In 1999 Abigail Burroughs, a nineteen year old University of Virginia student, was diagnosed with a rare cancer of the head and neck. For eighteen months, she underwent painful chemotherapy and radiation treatments, those approved by FDA, to no avail. In March of 2001, Abigail and her parents were informed that the FDA approved treatments had failed and that her only hope lay in gaining access to investigational drugs, Erbitux and Iressa, then undergoing clinical trials. Abigail’s cancer cells had very high Epidermal Growth Factor Receptors, and EGFRs had been shown preliminarily to be greatly suppressed by these two experimental drugs. The sponsors of the drug trials were willing to provide the experimental drugs to Abigail, but they had to first obtain the consent of the FDA. The FDA refused to grant its consent, and Abigail died on June 9, 2001, at the age of twenty-one.

In the spring of 2001 sixteen year old high school student David Baxter was diagnosed with colorectal cancer. Although there was little chance that FDA approved chemotherapy would be successful, he proceeded through his chemotherapy rounds. David was denied access to investigational drugs by FDA on the basis that he was not yet eighteen, and the trials were said to be only available for those eighteen and older. He died shortly before his seventeenth birthday on July 20, 2002.

Kianna Karnes was a forty-four year old mother of four and grandmother of one when she was diagnosed with kidney cancer that was said to have metastasized. Two different investigational drugs, BAY 43-9006 and SU 11248, were promising for what was regarded as an otherwise untreatable disease. Despite appeals for access to the drugs, FDA refused to grant access until her condition had advanced to its final stage. FDA refused to grant Karnes access to one of the experimental drugs but finally changed its position, issuing notice of a grant of access to Karnes on the day she died in 2005.

Thirteen year old Anna Tomalis was diagnosed with embryonal sarcoma. She underwent FDA approved chemotherapy and surgery but both failed. Her parents then endeavored to have Anna treated with an investigational drug, Deforolimus, developed by Merck and ARIAD. FDA refused to grant Tomalis access to the drug until three weeks before she died, at a stage of cancer progression beyond that effectively treatable by the investigational drug.

Many, like Patricia Clarkson (the subject of my article for Newswithviews entitled FDA Condemnation of the Terminally Ill), are presently diagnosed with terminal cancer and have been informed that FDA approved treatments are not likely efficacious, yet their requests for access to investigational drugs have been denied by the FDA.

On August 3, 2012, Congressman Ron Paul introduced the Compassionate Freedom of Choice Act, HR 6342. Under that bill, if a patient has been diagnosed with a terminal illness and a physician has determined that FDA approved drugs and devices are unlikely to be curative, the patient may obtain access to an investigational drug if the sponsor is willing to supply it and the patient executes an informed consent. The bill removes FDA from the picture, restoring medical freedom to the patient and the practice of medicine to attending physicians. The bill also removes a perverse incentive now present in FDA regulations. FDA requires sponsors of clinical trials to report the results of treatments to those given compassionate access. Because adverse findings may have an impact on drug approval, sponsors are often dissuaded from granting access for fear that it will redound to their detriment in the drug approval process. Congressman Paul’s bill eliminates the requirement that any information concerning compassionate access be supplied to the FDA.

Congressman Paul’s bill is co-sponsored by Congressmen Charles Broun of Georgia and Richard L. Hanna of New York. It is pending before the House Energy and Commerce Committee, chaired by Fred Upton of Michigan. On this bill depends the lives of many terminally ill patients. Without the bill, every terminally ill patient who seeks access to an experimental drug must grovel before the FDA, begging for the right to receive the drug which is that person’s only hope for survival. No American, and certainly none fighting to remain alive, should be subjected to that humiliation, and no person in government, and certainly not an FDA bureaucrat, should ever stand between the terminally ill and access to a potentially life-saving drug.

I list here each member of the Energy and Commerce Committee. Please examine the list. If your member of Congress is on it, I urge you to call or email him or her today. Ask your representative to co-sponsor HR 6342. If your member of Congress is not on this list, please call or email the chairman of the committee, Fred Upton of Michigan, and urge him to co-sponsor this bill. This is not a partisan issue, it is a humanitarian measure of critical and immediate need.

Republican Members, 112th Congress

Fred Upton (MI)
Joe Barton (TX)
Cliff Stearns (FL)
Ed Whitfield (KY)
John Shimkus (IL)
Joseph R. Pitts (PA)
Mary Bono Mack (CA)
Greg Walden (OR)
Lee Terry (NE)
Mike Rogers (MI)
Sue Myrick (NC)
John Sullivan (OK)
Tim Murphy (PA)
Michael Burgess (TX)
Marsha Blackburn (TN)
Brian P. Bilbray (CA)
Charles F. Bass (NH)
Phil Gingrey (GA)
Steve Scalise (LA)
Bob Latta (OH)
Cathy McMorris Rodgers (WA)
Gregg Harper (MS)
Leonard Lance (NJ)
Bill Cassidy (LA)
Brett Guthrie (KY)
Pete Olson (TX)
David McKinley (WV)
Cory Gardner (CO)
Mike Pompeo (KS)
Adam Kinzinger (IL)
Morgan Griffith (VA)

Democrat Members, 112th Congress

Henry A. Waxman (CA)
John D. Dingell (MI)
Edward J. Markey (MA)
Edolphus Towns (NY)
Frank Pallone, Jr. (NJ)
Bobby L. Rush (IL)
Anna G. Eshoo (CA)
Eliot L. Engel (NY)
Gene Green (TX)
Diana DeGette (CO)
Lois Capps (CA)
Michael F. Doyle (PA)
Jan Schakowsky (IL)
Charles A. Gonzalez (TX)
Tammy Baldwin (WI)
Mike Ross (AR)
Jim Matheson (UT)
G. K. Butterfield (NC)
John Barrow (GA)
Doris O. Matsui (CA)
Donna Christensen (VI)
Kathy Castor (FL)
John Sarbanes (MD)

© 2012 Jonathan W. Emord – All Rights Reserved

Jonathan W. Emord is an attorney who practices constitutional and administrative law before the federal courts and agencies. Congressman Ron Paul calls Jonathan “a hero of the health freedom revolution” and says “all freedom-loving Americans are in [his] debt . . . for his courtroom [victories] on behalf of health freedom.” He has defeated the FDA in federal court a remarkable eight times, six on First Amendment grounds, and is the author of Amazon bestsellers The Rise of TyrannyGlobal Censorship of Health Information, andRestore the Republic. He is also the American Justice columnist for U.S.A. Today Magazine. For more info visit Emord.com.

Read the full article and comment here:  http://www.thenhf.com/article.php?id=3433

 

Global Censorship of Health Information
The Politics of Controlling Therapeutic Information to Protect State-Sponsored Drug Monopolies

Global Censorship of Health Information book coversm FDA Stands Between Terminally Ill And Experimental Drugs

by Attorney Jonathan Emord
Free Shipping available!


0 commentsback to post

Other articlesgo to homepage

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Will India be First Country to Revoke Marketing Licenses for HPV Vaccines?

Pin It

A petition currently before the Supreme Court of India alleges that the Drugs Controller of India issued licenses for Gardasil and Cervarix without adequate research on safety as directed by the Parliamentary Standing Committee on Health and Family Welfare.

Petition number 558/2012, filed by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, seeks to resolve this and several other issues by asking the Supreme Court of India to rescind the licenses for marketing and administration of HPV vaccines, make provisions to identify and treat any girls left with chronic health problems and/or autoimmune disorders after their participation in HPV vaccine trials, blacklist the Program for Appropriate Technology in Health (PATH), and allow no other foreign agencies to have a field presence in India.

Will India be the first country in the world to revoke the marketing licenses for Gardasil and Cervarix? Will the Supreme Court of India move to protect the health and welfare of their young citizens, or the interests of the HPV vaccine manufacturers? Will PATH and similar agencies be banned from operating in India?
Will the victims of adverse reactions to HPV vaccines be located and treated? We can only hope these questions will be answered when the final hearing will take place.

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys

Pin It

A top research scientist working for the Centers for Disease Control and Prevention (CDC) played a key role in helping Dr. Brian Hooker of the Focus Autism Foundation uncover data manipulation by the CDC that obscured a higher incidence of autism in African-American boys.

“We’ve missed ten years of research because the CDC is so paralyzed right now by anything related to autism. They’re not doing what they should be doing because they’re afraid to look for things that might be associated.” The whistleblower alleges criminal wrongdoing of his supervisors, and he expressed deep regret about his role in helping the CDC hide data.

The Cancer Industry is Too Prosperous to Allow a Cure

The Cancer Industry is Too Prosperous to Allow a Cure

Pin It

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it.

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

800,000 Die from Blindly Trusting Their Doctor’s Prescription for This Pre-Surgery Drug

Pin It

European doctors may have caused as many as 800,000 deaths in five years by following the “standard of care” to use beta-blockers in non-cardiac surgery patients—a guideline based largely on discredited science.

Tylenol: The Killer Drug Your Children can Buy

Tylenol: The Killer Drug Your Children can Buy

Pin It

Is there any more doubt that acetaminophen (Tylenol) is the most dangerous over-the-counter drug ever allowed to be sold legally without a prescription? Consider the facts:

Acetaminophen kills almost 500 people a year due to acute liver failure.
Acetaminophen overdose is the leading cause for calls to Poison Control Centers – more than 100,000/year.
Acetaminophen accounts for more than 56,000 emergency room visits, 2,600 hospitalizations.
Acetaminophen poisoning causes nearly 50% of all acute liver failure in the United States.
Acetaminophen is linked to fatal skin reactions.
Acetaminophen causes a two-fold increased risk of blood cancer.
Acetaminophen can cause an increase in autism, attention deficit with hyperactivity, and asthma when used with vaccines.

And yet, any child can walk into a drug store or grocery store and buy it like candy. Alliance for Natural Health brings us the latest bad news on Tylenol:

A study just published in JAMA Pediatrics finds that Tylenol (acetaminophen) taken by women during their pregnancy may raise the risk of ADHD (Attention Deficit Hyperactive Disorder) and similar disorders in their children up to 40%—with the risk increasing the more acetaminophen the mother takes.

read more


Get the news right in your inbox!